"Providence Medical Research Center allows Pacific Northwest residents to have access to the latest advances in medical research through Providence-affiliated clinicians and physician investigators. These providers’ specialties include heart and vascular diseases, kidney disease, diabetes, high blood pressure, nutrition, bowel disease, cancer and more. Located at Sacred Heart Medical Center & Children’s Hospital, our center is the only physician-led comprehensive medical research center in the Inland Northwest. We coordinate a diverse spectrum of research studies via federally funded programs and industry-sponsored drug and device trials."

During the past decade, Providence Medical Research Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Medical Research Center" #1 sponsor was "Providence Health & Services" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Actelion" with 2 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Medical Research Center" #1 collaborator was "Providence Medical Research Center" with 2 trials as a collaborator, "The Heart Institute of Spokane" with 2 trials as a collaborator, "University of Washington" with 2 trials as a collaborator, "ActiGraph LLC" with 1 trials as a collaborator and "Almac Clinical Technologies" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Providence Medical Research Center" are "Chronic Kidney Disease" (2 trials), "Glomerulonephritis" (2 trials), "Glomerulosclerosis, Focal Segmental" (2 trials), "Kidney Diseases" (2 trials) and "Nephritis" (2 trials). Many other conditions were trialed in "Providence Medical Research Center" in a lesser frequency.

Most popular intervention types in "Providence Medical Research Center" are "Drug" (19 trials), "Device" (7 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "GFB-887" (2 trials), "Oral treprostinil" (2 trials) and "5 ASA, enemas, suppositories, corticosteroids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Medical Research Center" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Providence Medical Research Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Providence Medical Research Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Medical Research Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".